Sign Up Today and Learn More About Vaxxas Stock
Invest in or calculate the value of your shares in Vaxxas or other pre-IPO companies through EquityZen's platform.
Vaxxas Stock (VAXX)
Vaxxass is a biotechnology company focused on needle-free vaccination technology.
About Vaxxas Stock
Founded
2011
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Vaxxas Press Mentions
Stay in the know about the latest news on Vaxxas
Microprojection arrays with enhanced skin penetrating properties and methods …
patents • Apr 02, 2025
Covid vaccine delivered by hd-map
patents • Apr 02, 2025
Other news to note for March 7, 2025
bioworld • Mar 09, 2025
Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology
biospace • Mar 05, 2025
Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology
businesswire • Mar 04, 2025
Vaxxas Management
Leadership team at Vaxxas
Board Member
Paul Kelly
Chief Financial Officer
Doug Cubbin
Join now and verify your accreditation status to gain access to:
- Vaxxas Current Valuation
- Vaxxas Stock Price
- Vaxxas Management
- Available deals in Vaxxas and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vaxxas Cap Table and Funding History by Share Class and Liquidity Preferences
- Vaxxas Revenue and Financials
- Vaxxas Highlights
- Vaxxas Business Model
- Vaxxas Risk Factors
- Vaxxas Research Report from SACRA Research
Trading Vaxxas Stock
How to invest in Vaxxas stock?
Accredited investors can buy pre-IPO stock in companies like Vaxxas through EquityZen funds. These investments are made available by existing Vaxxas shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vaxxas stock?
Shareholders can sell their Vaxxas stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
